2019 Annual Meeting | C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know

Date Monday 05/06/19

Time 01:00 PM - 03:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alison M. Pack, MD, FAAN

Topic(s) General Neurology

Learning Objectives Participants should be able to understand how neuroendocrine anatomy and humoral relationships influence the presentation and treatment of epilepsy, multiple sclerosis, and headache, as well as understand the impact of trauma on the neuroendocrine system.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EDT	Introduction	Introduction Alison M. Pack, MD, FAAN
01:05 PM - 01:25 PM EDT	Speaker	Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond Karen K. Miller, MD
01:25 PM - 01:45 PM EDT	Speaker	Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects Alison M. Pack, MD, FAAN
01:45 PM - 02:05 PM EDT	Speaker	Influence of Neuroendocrine System on Multiple Sclerosis Riley Bove, MD, FAAN
02:05 PM - 02:25 PM EDT	Speaker	Neuroendocrine Effects on Headache Michael A. Rogawski, MD, PhD
02:25 PM - 02:45 PM EDT	Speaker	Effects of Neurotrauma on the Neuroendocrine System Gary M. Abrams, MD, FAAN
02:45 PM - 03:00 PM EDT	Q&A	Questions and Answers

Faculty Disclosures
Alison M. Pack, MD, FAAN	An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Karen K. Miller, MD	Dr. Klahr Miller has stock in Amgen. Dr. Klahr Miller has stock in Bristol-Myers Squibb . Dr. Klahr Miller has stock in GE. Dr. Klahr Miller has stock in Boston Scientific. Dr. Klahr Miller has stock in Becton Dickinson. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . An immediate family member of Dr. Klahr Miller has stock in GE. An immediate family member of Dr. Klahr Miller has stock in Boston Scientific. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . The institution of Dr. Klahr Miller has received research support from Amgen. The institution of Dr. Klahr Miller has received research support from Pfizer. Dr. Klahr Miller has received publishing royalties from a publication relating to health care.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Gary M. Abrams, MD, FAAN	No disclosure on file
Michael A. Rogawski, MD, PhD	Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.

��ɫ��

��ɫ��